Coumestrol Inhibits Proliferation and Migration of Prostate Cancer Cells by Regulating AKT, ERK1/2, and JNK MAPK Cell Signaling Cascades

Journal of Cellular Physiology

Volumn 232, Issue 4, 2017, Pages 862-871

  Lim, Whasun ^a   Jeong, Muhah ^a   Bazer, Fuller W ^b   Song, Gwonhwa ^a  

^a Korea University   (South Korea)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; COUMESTROL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR SIGNALING; LNCAP CELL LINE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COUMESTROL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 84979687783     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25494     Document Type: Article

References (34)

1. Altintop MD, Sever B, Ozdemir A, Kus G, Oztopcu-Vatan P, Kabadere S, Kaplancikli ZA. 2016. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells. J Enzyme Inhib Med Chem 31:410–416.
2. Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ. 2003. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 63:1981–1989.
3. Bode AM, Dong Z. 2013. Signal transduction and molecular targets of selected flavonoids. Antioxid Redox signal 19:163–180.
4. Bravo-Cordero JJ, Hodgson L, Condeelis J. 2012. Directed cell invasion and migration during metastasis. Curr Opin Cell Biol 24:277–283.
5. Canal Castro C, Pagnussat AS, Orlandi L, Worm P, Moura N, Etgen AM, Alexandre Netto C. 2012. Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats. Brain Res 1474:82–90.
6. Cho SY, Cho S, Park E, Kim B, Sohn EJ, Oh B, Lee EO, Lee HJ, Kim SH. 2014. Coumestrol suppresses hypoxia inducible factor 1alpha by inhibiting ROS mediated sphingosine kinase 1 in hypoxic PC-3 prostate cancer cells. Bioorg Med Chem Lett 24:2560–2564.
7. Connolly RM, Carducci MA, Antonarakis ES. 2012. Use of androgen deprivation therapy in prostate cancer: Indications and prevalence. Asian J Androl 14:177–186.
8. Cunningham D, You Z. 2015. In vitro and in vivo model systems used in prostate cancer research. J Biol Methods 2:e17.
9. Dhillon AS, Hagan S, Rath O, Kolch W. 2007. MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290.
10. Hu W, Kavanagh JJ. 2003. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4:721–729.
11. Huggins C, Hodges CV. 2002. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 168:9–12.
12. Kang S, Kim JE, Li Y, Jung SK, Song NR, Thimmegowda NR, Kim BY, Lee HJ, Bode AM, Dong Z, Lee KW. 2015. Hirsutenone in Alnus extract inhibits akt activity and suppresses prostate cancer cell proliferation. Mol Carcinog 54:1354–1362.
13. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS, Jr. 2000. Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9:795–804.
14. Koo J, Cabarcas-Petroski S, Petrie JL, Diette N, White RJ, Schramm L. 2015. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein. BMC Cancer 15.
15. Kumar R, Verma V, Jain A, Jain RK, Maikhuri JP, Gupta G. 2011. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J Nutr Biochem 22:723–731.
16. Lall RK, Syed DN, Adhami VM, Khan MI, Mukhtar H. 2015. Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci 16:3350–3376.
17. Lee YH, Yuk HJ, Park KH, Bae YS. 2013. Coumestrol induces senescence through protein kinase CKII inhibition-mediated reactive oxygen species production in human breast cancer and colon cancer cells. Food Chem 141:381–388.
18. Lesinski GB, Reville PK, Mace TA, Young GS, Ahn-Jarvis J, Thomas-Ahner J, Vodovotz Y, Ameen Z, Grainger E, Riedl K, Schwartz S, Clinton SK. 2015. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prev Res 8:1036–1044.
19. Lim EJ, Heo J, Kim YH. 2015. Tunicamycin promotes apoptosis in leukemia cells through ROS generation and downregulation of survivin expression. Apoptosis 20:1087–1098.
20. Liu K, Park C, Chen H, Hwang J, Thimmegowda NR, Bae EY, Lee KW, Kim HG, Liu H, Soung NK, Peng C, Jang JH, Kim KE, Ahn JS, Bode AM, Dong Z, Kim BY, Dong Z. 2015. Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling. Mol Carcinog 54:751–760.
21. Mitchell JH, Duthie SJ, Collins AR. 2000. Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP. Nutr Cancer 38:223–228.
22. Mukherjee R, McGuinness DH, McCall P, Underwood MA, Seywright M, Orange C, Edwards J. 2011. Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. Br J Cancer 104:1920–1928.
23. Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, Lee BC, Cheng C, Chung MK, Fukagai T, Hinotsu S, Horie S. 2010. Prostate cancer working group report. Jpn J Clin Oncol 40:i70–i75.
24. Obiorah IE, Fan P, Jordan VC. 2014. Breast cancer cell apoptosis with phytoestrogens is dependent on an estrogen-deprived state. Cancer Prev Res 7:939–949.
25. Pammolli F, Magazzini L, Riccaboni M. 2011. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov 10:428–438.
26. Patisaul HB, Jefferson W. 2010. The pros and cons of phytoestrogens. Front Neuroendocrinol 31:400–419.
27. Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, Murphy MP. 2000. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475:267–272.
28. Seruga B, Ocana A, Tannock IF. 2011. Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol 8:12–23.
29. Shiota M, Eto M. 2016. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer. Int J Urol 23:360–369.
30. Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. CA Cancer J Clin 65:5–29.
31. Tse G, Eslick GD. 2016. Soy and isoflavone consumption and risk of gastrointestinal cancer: A systematic review and meta-analysis. Eur J Nutr 55:63–73.
32. Wang Z, Wang J, Xie R, Liu R, Lu Y. 2015. Mitochondria-derived reactive oxygen species play an important role in Doxorubicin-induced platelet apoptosis. Int J Mol Sci 16:11087–11100.
33. Wu XT, Wang B, Wei JN. 2009. Coumestrol promotes proliferation and osteoblastic differentiation in rat bone marrow stromal cells. J Biomed Mater Res B Appl Biomater 90:621–628.
34. Zhong P, Wu L, Qian Y, Fang Q, Liang D, Wang J, Zeng C, Wang Y, Liang G. 2015. Blockage of ROS and NF-kappaB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries. Biochim Biophys Acta 1852:1230–1241.